A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations
Public ClinicalTrials.gov record NCT03955913. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Biomarker Study to Identify Subjects With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations
Study identification
- NCT ID
- NCT03955913
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Enrollment
- 3,679 participants
Conditions and interventions
Interventions
- Archival Tumor Tissue Sample Other
Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2019
- Primary completion
- Sep 18, 2022
- Completion
- Sep 18, 2022
- Last update posted
- Feb 23, 2023
2019 – 2022
United States locations
- U.S. sites
- 23
- U.S. states
- 12
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Oncology Associates, PC - HOPE | Tucson | Arizona | 85711 | — |
| Rocky Mountain Cancer Centers | Denver | Colorado | 80218 | — |
| Medical Oncology Hematology Consultants, PA | Newark | Delaware | 19713 | — |
| Affiliated Oncologists, LLC | Chicago Ridge | Illinois | 60415 | — |
| Maryland Oncology Hematology, PA | Brandywine | Maryland | 20613 | — |
| Minnesota Oncology Hematology, P.A. | Minneapolis | Minnesota | 55404 | — |
| New York Oncology Hematology | Albany | New York | 12206 | — |
| Broome Oncology | Johnson City | New York | 13790 | — |
| Oncology Hematology Care | Cincinnati | Ohio | 45242 | — |
| Willamette Valley Cancer Institute and Research Center | Eugene | Oregon | 97401 | — |
| Northwest Cancer Specialists PC | Tualatin | Oregon | 97062 | — |
| Consultants in Medical Oncology and Hematology, P.C. - Abington | Horsham | Pennsylvania | 19044 | — |
| Texas Oncology-Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | — |
| Texas Oncology-Denton South | Denton | Texas | 76210 | — |
| Texas Oncology, P.A. - Flower Mound | Flower Mound | Texas | 75028 | — |
| Texas Oncology-Fort Worth Cancer Center | Fort Worth | Texas | 76104 | — |
| Texas Oncology-Memorial City | Houston | Texas | 77024 | — |
| Texas Oncology-Midland Allison Cancer Center | Midland | Texas | 79701 | — |
| University of Texas at San Antonio | San Antonio | Texas | 78217 | — |
| Texas Oncology-Sherman | Sherman | Texas | 75090 | — |
| Texas Oncology-Tyler | Tyler | Texas | 75702 | — |
| Texas Oncology -Waco | Waco | Texas | 76712 | — |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 176 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03955913, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 23, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03955913 live on ClinicalTrials.gov.